Cooley advised FibroGen on its $120 million shelf takedown of 5,228,750 shares of common stock. FibroGen, which is headquartered in San Francisco and trades on The…
FibroGen’s $120 Million Shelf Takedown
Cooley advised FibroGen on its $120 million shelf takedown of 5,228,750 shares of common stock. FibroGen, which is headquartered in San Francisco and trades on The…